Development of M102 to investigational new drug (IND) stage for initiation of phase i clinical trials for treating amyotrophic lateral sclerosis (ALS)
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210175
- Recipient
-
Aclipse One Inc. UEI MZLCZ85WT6P8 Part of Aclipse Therapeutics LLC
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,475,101
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Wayne, PA 19087, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $1,475,101 |
Quick answers
Who received award W81XWH2210175?
W81XWH2210175 was awarded to Aclipse One Inc. by Defense Health Agency (Department of Defense) on April 1, 2022.
How much is award W81XWH2210175 worth?
$1,475,101 has been obligated on W81XWH2210175.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award